RxDoctor Payments Data

Erin Clayton

Nurse Practitioner · Beloit, WINPI 1396403689

Payments from drug & device makers

$1,144in general payments, 2019–2025

Across 35 payments — averaging $32.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$454
  • Lilly USA, LLC$163
  • Dexcom, Inc.$138
  • Bayer$125
  • Boehringer Ingelheim$84
  • Exact Sciences$59
  • plus $120 from 5 others

What the payments were for

  • Food & beverage$1,144100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,144 in reported general payments places this provider in the 90th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$17,523
Medicare patients
121
Services billed
296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$69,761
OzempicSemaglutide35$43,649
MounjaroTirzepatide21$25,654
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$23,947
JanuviaSitagliptin Phosphate19$23,917
TrulicityDulaglutide15$20,427
JardianceEmpagliflozin13$13,002
JanumetSitagliptin Phos/Metformin Hcl13$12,160
Breo ElliptaFluticasone/Vilanterol14$10,006
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,953
SymbicortBudesonide/Formoterol Fumarate21$6,028
Albuterol Sulfate HfaAlbuterol Sulfate238$5,174
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$4,059
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen126$3,805
Gabapentin157$2,665

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$21$69,76169 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog$163$47,20048 claims
Novo NordiskOzempic$454$43,64935 claims
GSKTrelegy Ellipta, Breo Ellipta$20$33,95344 claims
Boehringer IngelheimJardiance$84$13,00213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Beloit

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →